279 results on '"R Boldrini"'
Search Results
2. Male subimago of Massartella venezuelensis Pescador & Peters, 1990 (Ephemeroptera: Leptophlebiidae).
- Author
-
Boldrini R and Lima LRC
- Subjects
- Male, Animals, Nymph, Ephemeroptera
- Published
- 2022
- Full Text
- View/download PDF
3. Updated records for Leptophlebiidae (Ephemeroptera) and a new species of Thraulodes Ulmer, 1920 from Tocantins State, Northern Brazil.
- Author
-
Orlando TY, Salles FF, Boldrini R, and Krolow TK
- Subjects
- Animals, Brazil, Male, Ephemeroptera
- Abstract
An annotated checklist with complementary information for leptophlebiid mayflies from Tocantins State, Brazil is provided. Additionally, we describe a new species of Thraulodes Ulmer, 1920 based on male adults. New reports are based on collections conducted between August 2017 and August 2019 in 13 localities of 10 municipalities. A total of 436 adults distributed in 11 genera, 16 species and five morphospecies treated as undescribed species were collected. Of the total species examined, 11 are new records.
- Published
- 2021
- Full Text
- View/download PDF
4. Immunofluorescence mapping, electron microscopy and genetics in the diagnosis and sub-classification of inherited epidermolysis bullosa: a single-centre retrospective comparative study of 87 cases with long-term follow-up.
- Author
-
Rossi S, Castiglia D, Pisaneschi E, Diociaiuti A, Stracuzzi A, Cesario C, Mariani R, Floriddia G, Zambruno G, Boldrini R, Abeni D, Novelli A, Alaggio R, and El Hachem M
- Subjects
- Fluorescent Antibody Technique, Follow-Up Studies, Humans, Infant, Newborn, Retrospective Studies, Epidermolysis Bullosa diagnosis, Epidermolysis Bullosa genetics, Epidermolysis Bullosa, Junctional diagnosis, Epidermolysis Bullosa, Junctional genetics
- Abstract
Background: Epidermolysis bullosa (EB) comprises a heterogeneous group of skin fragility disorders, classified in four major types based on skin cleavage level, i.e. EB simplex (EBS), junctional EB (JEB), dystrophic EB (DEB), Kindler EB, and in more than 30 subtypes defined by the combination of laboratory and clinical data, including disease course., Objectives: Our aims were to address whether, in the age of genomics, electron microscopy (TEM) has still a role in diagnosing EB, and whether the genotype per se may be sufficient to sub-classify EB., Methods: A thoroughly characterized single-centre EB case series was retrospectively evaluated to compare the power of TEM with immunofluorescence mapping (IFM) in establishing the EB type, and the ability of TEM, IFM and genetics to predict selected EB subtypes, i.e. severe dominant EBS (DEBS), severe JEB, severe recessive DEB (RDEB) and DEB self-improving, using genetic and final diagnosis, respectively, as gold standard., Results: The series consisted of 87 patients, including 44 newborns, with a median follow-up of 54 months. Ninety-five mutations were identified in EB-associated genes, including 25 novel variants. Both IFM and TEM were diagnostic in about all cases of JEB (21/21 for both) and DEB (43/44 for IFM, 44/44 for TEM). TEM sensitivity was superior to IFM for EBS (19/20 vs. 16/19). As to EB subtyping, IFM performed better than genetics in identifying severe JEB cases due to laminin-332 defect (14/14 vs. 10/14) and severe RDEB (eight/nine vs. seven/nine). Genetics had no role in self-improving DEB diagnosis; it almost equalled TEM in predicting severe DEBS (eight/nine vs. nine/nine) and enabled to discriminate dominant from recessive non-severe DEB phenotypes and to identify special subtypes, e.g. DEBS with KLHL24 mutations., Conclusions: Transmission electron microscopy remains relevant to the diagnosis of EBS. IFM and genetics are essential and complementary tools in the vast majority of EB cases., (© 2020 European Academy of Dermatology and Venereology.)
- Published
- 2021
- Full Text
- View/download PDF
5. Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma.
- Author
-
Melaiu O, Chierici M, Lucarini V, Jurman G, Conti LA, De Vito R, Boldrini R, Cifaldi L, Castellano A, Furlanello C, Barnaba V, Locatelli F, and Fruci D
- Subjects
- Adolescent, Adult, B7-H1 Antigen metabolism, Child, Child, Preschool, Cohort Studies, Datasets as Topic, Dendritic Cells immunology, Disease-Free Survival, Female, Humans, Infant, Killer Cells, Natural immunology, Lymphocytes, Tumor-Infiltrating immunology, Male, Middle Aged, Neuroblastoma genetics, Neuroblastoma immunology, Neuroblastoma pathology, Prognosis, Programmed Cell Death 1 Receptor metabolism, RNA-Seq, Sensitivity and Specificity, Survival Rate, T-Lymphocytes immunology, T-Lymphocytes metabolism, Tumor Microenvironment genetics, Tumor Microenvironment immunology, Young Adult, Dendritic Cells metabolism, Killer Cells, Natural metabolism, Lymphocytes, Tumor-Infiltrating metabolism, Neuroblastoma mortality, Transcriptome immunology
- Abstract
Tumor-infiltrating lymphocytes play an essential role in improving clinical outcome of neuroblastoma (NB) patients, but their relationship with other tumor-infiltrating immune cells in the T cell-inflamed tumors remains poorly investigated. Here we show that dendritic cells (DCs) and natural killer (NK) cells are positively correlated with T-cell infiltration in human NB, both at transcriptional and protein levels, and associate with a favorable prognosis. Multiplex imaging displays DC/NK/T cell conjugates in the tumor microenvironment of low-risk NB. Remarkably, this connection is further strengthened by the identification of gene signatures related to DCs and NK cells able to predict survival of NB patients and strongly correlate with the expression of PD-1 and PD-L1. In summary, our findings unveil a key prognostic role of DCs and NK cells and indicate their related gene signatures as promising tools for the identification of clinical biomarkers to better define risk stratification and survival of NB patients.
- Published
- 2020
- Full Text
- View/download PDF
6. Redescription of Apobaetis lakota McCafferty, 2000 (Ephemeroptera: Baetidae) and description of two new species from Brazil.
- Author
-
Cruz PV, Boldrini R, and Hamada N
- Subjects
- Animals, Brazil, Larva, Nymph, Ephemeroptera
- Abstract
The genus Apobaetis Day is known by its small size and larval shifting-sand habitat preference (psammophilous). Three species of this genus are recorded in North America, from these, only Apobaetis lakota McCafferty needs to be redescribed because its original description is incomplete, turning difficult to distinguish it from species with similar morphology. Therefore, one of the objectives of this study is to redescribe A. lakota. Based on this redescription, two new species from Brazil, with similar morphology could be identified and are described (Apobaetis biancae sp. nov. and Apobaetis jacobusi sp. nov.). Apobaetis lakota can be differentiated by the labrum rectangular, distal margin without medial emargination, medial area of distal margin with three sockets of setae on dorsal surface; maxillary palp long, more than 2.0× the length of galea-lacinia, segment I with the same length as galea-lacinia; lingua subcircular with one medial lobe; glossa distally rounded; inner projection of labial palp segment II rounded and distally directed, segment III triangular; tarsal claws 1.3× the length of tarsus, without row of denticles. Apobaetis jacobusi sp. nov. can be differentiated from other species by fore tarsal claw I with the same length of tarsus, labrum medially with two protuberances and glossa with pointed apex. Apobaetis biancae sp. nov. can be differentiated by the absence of a ventral row of long thin setae near distolateral margin of labrum, four marginal spines on the paraproct, a subrectangular hypopharynx, and by the absence of robust setae on inner margin of the glossa.
- Published
- 2020
- Full Text
- View/download PDF
7. The Crucial Role of Surgical Treatment in BIA-ALCL Prognosis in Early- and Advanced-Stage Patients.
- Author
-
Campanale A, Spagnoli A, Lispi L, Boldrini R, and Marletta M
- Subjects
- Adult, Aged, Breast Implantation instrumentation, Breast Implants adverse effects, Breast Neoplasms epidemiology, Breast Neoplasms etiology, Breast Neoplasms pathology, Device Removal, Female, Humans, Incidence, Italy epidemiology, Lymphoma, Large-Cell, Anaplastic epidemiology, Lymphoma, Large-Cell, Anaplastic etiology, Lymphoma, Large-Cell, Anaplastic pathology, Middle Aged, Neoplasm Staging, Postoperative Complications epidemiology, Postoperative Complications etiology, Postoperative Complications pathology, Prognosis, Prospective Studies, Time Factors, Treatment Outcome, Breast Implantation adverse effects, Breast Neoplasms secondary, Lymphoma, Large-Cell, Anaplastic surgery, Mastectomy methods, Postoperative Complications surgery
- Abstract
Background: Studies on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) are trying to optimize medical and surgical treatments for early and advanced stages of this disease. The aim of this article is to share the experience gathered on the authors' prospectively collected 46 well-documented cases., Methods: Italian physicians are obliged to report BIA-ALCL cases to the Italian Ministry of Health. Because of this cooperation with health care professionals, the competent authority has coordinated and centralized the collection of information for each patient in 46 cases of BIA-ALCL. Statistical analyses with cumulative incidence and corresponding 95 percent confidence interval are provided for each year, dividing the number of new cases that occurred in a defined year and the population at risk of experiencing BIA-ALCL during the same year., Results: The mean time to the onset of symptoms is reduced to 6.4 ± 3.77 years (range, 1 to 22 years). Increased knowledge has also shortened the average time to diagnosis, at 7.2 ± 3.71 years (range, 2 to 22 years). A late seroma appears in 91 percent of cases. The patient who died underwent limited surgery. The Italian incidence has been estimated as 2.8 per 100,000 patients receiving implants (95 percent CI, 0.88 to 4.84) in 2015; 2.1 (95 percent CI, 0.43 to 3.86) in 2016; 3.2 (95 percent CI, 1.11 to 5.31) in 2017; and 3.5 (95 percent CI, 1.36 to 5.78) in 2018., Conclusion: Although the number of cases has risen slightly, BIA-ALCL is still a rare disease with a stable incidence, easily recognized and with a favorable prognosis also in advanced stages if complete surgical excision is performed.
- Published
- 2020
- Full Text
- View/download PDF
8. Diversity of EPT (Ephemeroptera, Plecoptera, Trichoptera) Along Streams Fragmented by Waterfalls in the Brazilian Savanna.
- Author
-
Andrade ICP, Krolow TK, Boldrini R, and Pelicice FM
- Subjects
- Animal Distribution, Animals, Aquatic Organisms, Brazil, Grassland, Water Movements, Biodiversity, Ephemeroptera classification, Rivers
- Abstract
In stream ecosystems, waterfalls intercept the fluvial continuum and limit the dispersion of aquatic organisms. However, the barrier effect may be minimized or absent for insects whose life cycle is not restricted to the aquatic environment (i.e., winged adults), such as the orders Ephemeroptera, Plecoptera and Trichoptera (EPT). In this study, we investigated EPT diversity (abundance, richness, and composition) in savanna headwater streams (Cerrado Domain, Brazil) to investigate the hypothesis that large waterfalls have little effect on instream assemblage structure. During 2017 and 2018, we sampled EPTs and measured environmental conditions at reaches adjacent (downstream and upstream) to waterfalls (5 to 70 m high). We collected 2532 immature specimens of 33 genera, including the first record of 14 genera of Ephemeroptera, 11 Trichoptera, and three Plecoptera for the Tocantins State. Hydro-geomorphic and streambed conditions varied among sites, but they were not related to the presence of waterfalls. Assemblage structure was similar between downstream and upstream reaches, with no significant difference in taxa richness, abundance, and composition. This pattern was consistently observed considering all data combined, and each order separately. These results support the hypothesis that physical barriers have weak effects on EPT assemblages at small spatial scales, where strong dispersal and habitat similarity probably homogenizes the structure of local assemblages in stream corridors adjacent to large waterfalls. The study provides important information about factors driving the distribution of biodiversity in savanna streams, which are relevant to support conservation and management plans in the Brazilian Cerrado.
- Published
- 2020
- Full Text
- View/download PDF
9. Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
- Author
-
De Pasquale MD, D'Angelo P, Crocoli A, Boldrini R, Conte M, Bisogno G, Spreafico F, Inserra A, Biasoni D, Dall'Igna P, Siracusa F, Miele E, and Terenziani M
- Subjects
- Adolescent, Carboplatin administration & dosage, Child, Child, Preschool, Cisplatin administration & dosage, Deoxycytidine administration & dosage, Deoxycytidine analogs & derivatives, Etoposide administration & dosage, Female, Follow-Up Studies, Humans, Ifosfamide administration & dosage, Infant, Male, Neoplasm Recurrence, Local pathology, Neoplasms, Germ Cell and Embryonal pathology, Oxaliplatin administration & dosage, Paclitaxel administration & dosage, Prognosis, Remission Induction, Retrospective Studies, Survival Rate, Gemcitabine, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Drug Resistance, Neoplasm drug effects, Neoplasm Recurrence, Local drug therapy, Neoplasms, Germ Cell and Embryonal drug therapy, Salvage Therapy
- Abstract
Background: Malignant germ cell tumors (GCTs) are a heterogeneous group of rare neoplasms in children. Optimal outcome is achieved with multimodal therapies for patients with both localized and advanced disease, especially after the introduction of platinum-based chemotherapy regimens. In this respect, data on salvage treatment for children with relapsed or platinum-refractory disease are still limited., Methods: Retrospective analysis of data regarding patients affected by malignant GCTs with platinum-refractory or relapsed disease after first-line treatment according to AIEOP TCGM 2004 protocol was conducted., Results: Twenty-one patients, 15 females and 6 males, were considered for the analysis. All 21 patients received second-line conventional chemotherapy (SLCT), two of these immediately after surgery for local relapse removal. Two patients showed a progression of disease during SLCT and died of disease shortly thereafter, whereas 19 patients were in partial remission (PR) or complete remission (CR) after SLCT. Treatment after SLCT consisted in surgery on residual tumor mass (9/19) followed by high dose of chemotherapy (HDCT) with autologous hematopoietic stem cell support (16/19). The overall survival (OS) and event-free survival of the whole populations are 71% and 66.6%, respectively. Platinum-refractory patients OS is 54.5% compared with 91.5% of the relapsed group. There were no treatment-related deaths., Conclusion: SLCT followed or not by HDCT is an effective salvage treatment for children with relapsed/refractory GCTs. However, the role of HDCT following SLCT needs to be further investigated, especially regarding the identification of specific patient subgroups, which can benefit from this more intensive treatment., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
10. Hoarse cry in a newborn with epidermolysis bullosa simplex, generalized severe.
- Author
-
Diociaiuti A, Giancristoforo S, Pisaneschi E, Condorelli AG, Boldrini R, Zambruno G, and El Hachem M
- Subjects
- Epidermolysis Bullosa Simplex genetics, Humans, Infant, Newborn, Male, Crying, Epidermolysis Bullosa Simplex complications, Epidermolysis Bullosa Simplex pathology, Hoarseness etiology
- Abstract
Hoarse cry and respiratory stridor are the signs of potentially life-threatening laryngeal involvement in selected severe and frequently early lethal subtypes of inherited epidermolysis bullosa (EB). We present a newborn with generalized skin blistering and onychodystrophy who developed a hoarse cry and inspiratory stridor. Ultrastructural skin examination revealed tonofilament clumping in basal keratinocytes and genetic testing identified the de novo missense mutation p.Arg125Cys in the KRT14 gene, consistent with EB simplex generalized severe, which is characterized by major morbidity in infancy but a favorable long-term prognosis. The present case underlines the importance to consider EB simplex generalized severe in the differential diagnosis of EB infants presenting hoarseness and stridor., (© 2020 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
11. New species of the genus Macrogynoplax and new records of Anacroneuria (Plecoptera: Perlidae) from Roraima State, Brazil.
- Author
-
Menezes ET, Boldrini R, and Novaes MC
- Subjects
- Animals, Brazil, Neoptera, Coleoptera, Insecta
- Abstract
Adults of Plecoptera of the family Perlidae were studied from seven municipalities of Roraima State, Brazil. One new species of Macrogynoplax Enderlein, 1909 was discovered and is described. We also report seven species of Anacroneuria Klapálek 1909 that represent two new country records for Brazil, A. caraca Stark, 1995 and A. cruza Stark, 1995, and five species, A. atrifrons Klapálek, 1922, A. blanca Stark, 1995, A. minuta Klapálek 1922, A. marlieri Froehlich 2001 and A. pictipes Klapálek 1923 that are new records for Roraima State. Additionally, we reported variant specimens of A. marlieri and A. minuta.
- Published
- 2020
- Full Text
- View/download PDF
12. A new species of Macrelmis Motschulsky, 1859 (Coleoptera: Elmidae) and new records of Elmidae from Roraima State, northern Brazil.
- Author
-
DE Almeida MDLS, Fernandes AS, and Boldrini R
- Subjects
- Animals, Brazil, Coleoptera
- Abstract
A new species of Macrelmis Motschulsky, 1859 (Macrelmis rodrigoi sp. nov.) is described and illustrated based on specimens found in mountainous areas of the northern Roraima State, Brazil. Pagelmis amazonica Spangler, 1981, Potamophilops bostrychophallus Maier, 2013 and Stegoelmis geayi Spangler, 1990 are recorded in Brazil for the first time and new records for Gyrelmis obesa Hinton, 1940, Macrelmis thorpei Hinton, 1945 and Neolimnius palpalis Hinton, 1939 are presented.
- Published
- 2020
- Full Text
- View/download PDF
13. A new species of Simothraulopsis Demoulin, 1966 (Ephemeroptera: Leptophlebiidae) from Tocantins state, Brazil.
- Author
-
Orlando TY, Krolow TK, and Boldrini R
- Subjects
- Animals, Brazil, Male, Ephemeroptera
- Abstract
There are seven genera and eight species of mayflies recorded for Tocantins state, Brazil, but only three belonging to the family Leptophlebiidae. Based on male imagoes, Simothraulopsis primus sp. nov. is described from Tocantins state, Northern Brazil. The species is characterized by the male genitalia being short, lanceolate, with a straight spine and by the "U" shape between the penis lobes. Other distinguishing features are the brown thorax and yellowish brown abdomen.
- Published
- 2019
- Full Text
- View/download PDF
14. Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension.
- Author
-
Galambos C, Mullen MP, Shieh JT, Schwerk N, Kielt MJ, Ullmann N, Boldrini R, Stucin-Gantar I, Haass C, Bansal M, Agrawal PB, Johnson J, Peca D, Surace C, Cutrera R, Pauciulo MW, Nichols WC, Griese M, Ivy D, Abman SH, Austin ED, and Danhaive O
- Subjects
- Adolescent, Adult, Child, Child, Preschool, DNA Copy Number Variations, Female, Genetic Variation, Heterozygote, Humans, Infant, Infant, Newborn, Lung growth & development, Lung Transplantation, Male, Mutation, Phenotype, Vascular Resistance, Young Adult, Gene Deletion, Hypertension, Pulmonary genetics, T-Box Domain Proteins genetics
- Abstract
Rare variants in the T-box transcription factor 4 gene ( TBX4 ) have recently been recognised as an emerging cause of paediatric pulmonary hypertension (PH). Their pathophysiology and contribution to persistent pulmonary hypertension in neonates (PPHN) are unknown. We sought to define the spectrum of clinical manifestations and histopathology associated with TBX4 variants in neonates and children with PH.We assessed clinical data and lung tissue in 19 children with PH, including PPHN, carrying TBX4 rare variants identified by next-generation sequencing and copy number variation arrays.Variants included six 17q23 deletions encompassing the entire TBX4 locus and neighbouring genes, and 12 likely damaging mutations. 10 infants presented with neonatal hypoxic respiratory failure and PPHN, and were subsequently discharged home. PH was diagnosed later in infancy or childhood. Three children died and two required lung transplantation. Associated anomalies included patent ductus arteriosus, septal defects, foot anomalies and developmental disability, the latter with a higher prevalence in deletion carriers. Histology in seven infants showed abnormal distal lung development and pulmonary hypertensive remodelling. TBX4 mutations and 17q23 deletions underlie a new form of developmental lung disease manifesting with severe, often biphasic PH at birth and/or later in infancy and childhood, often associated with skeletal anomalies, cardiac defects, neurodevelopmental disability and other anomalies., Competing Interests: Conflict of interest: C. Galambos has nothing to disclose. Conflict of interest: M.P. Mullen has acted as a site principal investigator on trials sponsored by United Therapeutics, Actelion, Ikaria and GSK, and received travel support from Actelion, outside the submitted work. Conflict of interest: J.T. Shieh has nothing to disclose. Conflict of interest: N. Schwerk has nothing to disclose. Conflict of interest: M.J. Kielt has nothing to disclose. Conflict of interest: N. Ullmann has nothing to disclose. Conflict of interest: R. Boldrini has nothing to disclose. Conflict of interest: I. Stucin-Gantar has nothing to disclose. Conflict of interest: C. Haass has nothing to disclose. Conflict of interest: M. Bansal has nothing to disclose. Conflict of interest: P.B. Agrawal has nothing to disclose. Conflict of interest: J. Johnson has nothing to disclose. Conflict of interest: D. Peca has nothing to disclose. Conflict of interest: C. Surace has nothing to disclose. Conflict of interest: R. Cutrera has nothing to disclose. Conflict of interest: M.W. Pauciulo has nothing to disclose. Conflict of interest: W.C. Nichols has nothing to disclose. Conflict of interest: M. Griese has nothing to disclose. Conflict of interest: D. Ivy has contracts (through the University of Colorado School of Medicine) with Actelion, Bayer, Lilly and United Therapeutics for consultancy and research studies. Conflict of interest: S.H. Abman has nothing to disclose. Conflict of interest: E.D. Austin has nothing to disclose. Conflict of interest: O. Danhaive has nothing to disclose., (Copyright ©ERS 2019.)
- Published
- 2019
- Full Text
- View/download PDF
15. A new species of Camelobaetidius Demoulin, 1966 (Ephemeroptera: Baetidae), from the Colombian Orinoco River basin.
- Author
-
Salinas-Jimenez LG, Boldrini R, Osorio-Ramirez DP, Caro CI, and Rojas-Peña JI
- Subjects
- Animals, Colombia, Nymph, Rivers, Ephemeroptera
- Abstract
Three species of Camelobaetidius Demoulin, 1966 have been reported from Colombia until now, based on nymphs. We describe a fourth species based on nymphs from the Colombian Orinoco river basin. The new species can be recognized by: 1) labrum narrowly rounded anteriorly; 2) segment II of labial palp with a short rounded distomedial projection; 3) incisors of right mandible with eleven denticles; 4) gills absent from the bases of coxae; 5) tarsal claws with ten denticles; 6) outer margin of forefemur with a row of about 23 long, spine-like setae; 7) posterior margin of tergum IV with truncate spines, and 8) terminal filament almost as long as cerci. [Zoobank URL: urn:lsid:zoobank.org:act:500CF998-8EF3-43E3-BA8B-F062B92768F3].
- Published
- 2019
- Full Text
- View/download PDF
16. Next Generation Sequencing Uncovers a Rare Case of X-linked Ichthyosis in an Adopted Girl Homozygous for a Novel Nonsense Mutation in the STS Gene.
- Author
-
Diociaiuti A, Angioni A, Pisaneschi E, Margollicci M, Boldrini R, Alesi V, Novelli A, Zambruno G, and El Hachem M
- Subjects
- Child, Female, Genetic Predisposition to Disease, Humans, Ichthyosis, X-Linked diagnosis, Ichthyosis, X-Linked enzymology, Phenotype, Predictive Value of Tests, Adoption, Codon, Nonsense, DNA Mutational Analysis methods, High-Throughput Nucleotide Sequencing, Homozygote, Ichthyosis, X-Linked genetics, Steryl-Sulfatase genetics
- Published
- 2019
- Full Text
- View/download PDF
17. Phenotypic Features of Epidermolysis Bullosa Simplex due to KLHL24 Mutations in 3 Italian Cases.
- Author
-
El Hachem M, Barresi S, Diociaiuti A, Boldrini R, Condorelli AG, Capoluongo E, Proto V, Scuvera G, Has C, Tartaglia M, and Castiglia D
- Subjects
- Child, DNA Mutational Analysis, Female, Genetic Predisposition to Disease, Humans, Infant, Newborn, Italy, Male, Phenotype, Prognosis, Wound Healing, Epidermolysis Bullosa Simplex genetics, Epidermolysis Bullosa Simplex pathology, Mutation, Repressor Proteins genetics, Skin pathology
- Published
- 2019
- Full Text
- View/download PDF
18. Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors.
- Author
-
Boldrini R, De Pasquale MD, Melaiu O, Chierici M, Jurman G, Benedetti MC, Salfi NC, Castellano A, Collini P, Furlanello C, Pistoia V, Cifaldi L, Terenziani M, and Fruci D
- Abstract
Although pediatric malignant extracranial germ-cell tumors (meGCTs) are among the most chemosensitive solid tumors, a group of patients relapse and die of disease. To identify new markers predicting clinical outcome, we examined the prognostic relevance of tumor-infiltrating T lymphocytes (TILs) and the expression of PD-1 and PD-L1 in a cohort of pediatric meGCTs by in situ immunohistochemistry. MeGCTs were variously infiltrated by T cell-subtypes according to the tumor subtype, tumor location and age at diagnosis. We distinguished three different phenotypes: i) tumors not infiltrated by T cells (immature teratomas and half of the yolk sac tumors), ii) tumors highly infiltrated by CD8
+ T cells expressing PD-1, which identifies activated tumor-reactive T cells (seminomas and dysgerminomas), iii) tumors highly infiltrated by CD8+ T cells within an immunosuppressive tumor microenvironment characterized by CD4+ FOXP3+ Treg cells and PD-L1-expressing tumor cells (embryonal carcinomas, choriocarcinomas and the remaining yolk sac tumors). Tumor subtypes belonging mixed meGCTs were variously infiltrated, suggesting the coexistence of multiple immune microenvironments either facilitating or precluding the entry of T cells. These findings support the hypothesis that TILs influence the development of meGCTs and might be of clinical relevance to improve risk stratification and the treatment of pediatric patients.- Published
- 2018
- Full Text
- View/download PDF
19. New species and new record of Thraulodes Ulmer, 1920 (Ephemeroptera: Leptophlebiidae: Atalophlebiinae) from Brazil.
- Author
-
Boldrini R, Dantas HATP, and Lima LRC
- Subjects
- Animals, Brazil, Male, Ephemeroptera
- Abstract
A new species of the mayfly genus Thraulodes is described based on specimens from the state of Roraima, Brazil. The male imago of Thraulodes rodrigoi sp. nov. is described and the new species can be easily recognized by: forewing with one weakly marked cross veins basal to bullae; femora of forelegs with an apical transversal band brown heavily marked and one submedian macula; styliger plate triangular with a medial rounded projection; and penes short and wide, without lateral pouch. Thraulodes sternimaculatus Lima, Mariano Pinheiro, 2013 is also reported for the first time in Piauí State.
- Published
- 2018
- Full Text
- View/download PDF
20. Malignant testicular germ cell tumors in children and adolescents: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) protocol.
- Author
-
Terenziani M, De Pasquale MD, Bisogno G, Biasoni D, Boldrini R, Collini P, Conte M, Dall'Igna P, Inserra A, Melchionda F, Siracusa F, Spreafico F, Barretta F, and D'Angelo P
- Subjects
- Adolescent, Bleomycin administration & dosage, Chemotherapy, Adjuvant methods, Child, Child, Preschool, Cisplatin administration & dosage, Disease-Free Survival, Etoposide administration & dosage, Humans, Infant, Kaplan-Meier Estimate, Male, Neoplasms, Germ Cell and Embryonal mortality, Neoplasms, Germ Cell and Embryonal surgery, Orchiectomy, Proportional Hazards Models, Testicular Neoplasms mortality, Testicular Neoplasms surgery, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Neoplasms, Germ Cell and Embryonal drug therapy, Testicular Neoplasms drug therapy
- Abstract
Objectives: We report the results of an Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) study on the treatment of testicular germ cell tumors (TGCT) with a pediatric PEB (pPEB) regimen (cisplatin 25 mg/m
2 daily on days 1-4; etoposide 100 mg/m2 daily on days 1-4; bleomycin 15 mg/m2 on day 2, once per cycle)., Methods and Materials: Male patients under 18 years old with malignant TGCT were enrolled for a second national prospective protocol. All patients underwent orchiectomy at diagnosis. Those with Stage I received no chemotherapy; those with Stage II-III disease received three cycles of pPEB; and those with Stage IV received four cycles. After chemotherapy, resection of radiologically-evident residual disease was recommended. The main study end-points were overall survival and relapse-free survival., Results: Ninety-nine boys from 0.5 to 17.8 years old (median 15.4 years) were evaluable, and staged as follows: 58 Stage I (59%), 7 Stage II (7%), 14 Stage III (14%), and 20 Stage IV (20%). With a median follow-up of 59 months (range 4-165 months), 5-year relapse-free survival (95% CI) was 73% (65%-83%) for the whole sample, 65% (53%-79%) for Stage I patients, and 86% (75%-98%) for Stage II-IV patients. Five-year overall survival (95% CI) was 99% (97%-100%)., Conclusions: We confirmed a good prognosis for malignant TGCT in children and adolescents. Reducing the number of chemotherapy cycles for Stage II-III disease does not seem to negatively affect survival outcomes., (Copyright © 2018. Published by Elsevier Inc.)- Published
- 2018
- Full Text
- View/download PDF
21. Ichthyosis Prematurity Syndrome due to a Novel SLC27A4 Homozygous Mutation in an Italian Patient.
- Author
-
Diociaiuti A, Rosati E, Paglietti MG, Vacca P, Boldrini R, Pisaneschi E, Castiglia D, Novelli A, and El Hachem M
- Subjects
- Biopsy, DNA Mutational Analysis, Genetic Predisposition to Disease, Humans, Ichthyosis diagnosis, Ichthyosis therapy, Infant, Infant, Newborn, Infant, Premature, Diseases diagnosis, Infant, Premature, Diseases therapy, Italy, Male, Phenotype, Fatty Acid Transport Proteins genetics, Homozygote, Ichthyosis genetics, Infant, Premature, Diseases genetics, Mutation
- Published
- 2018
- Full Text
- View/download PDF
22. New species and new records of Coryphorus Peters, 1981 (Ephemeroptera: Coryphoridae) from Brazil.
- Author
-
Lima LRC, Nascimento SRS, and Boldrini R
- Subjects
- Animals, Brazil, Male, Penis, Ephemeroptera
- Abstract
A new species Coryphorus is presented, based on recent collections from Northeastern Brazil and specimens deposited in the Museu Regional de Entomologia da Universidade Federal de Viçosa (UFVB) and Coleção Zoológica da Universidade Federal de Roraima (UFRR). Coryphorus molinerii sp. nov. is described based on male imagos and can be distinguished by the penis with rounded margins and forceps with segment II narrow and sharpening towards apex. Besides, C. aquilus Peters, (1981) is reported for Tocantins State for the first time.
- Published
- 2018
- Full Text
- View/download PDF
23. Description of the nymph of Miroculis (Miroculis) eldorado Gama-Neto Hamada, 2014 (Leptophlebiidae: Ephemeroptera) from Roraima, northern Brazil.
- Author
-
Boldrini R, Lima LRC, and Ottoni-Boldrini BMP
- Subjects
- Animals, Brazil, Coleoptera, Male, Ephemeroptera, Nymph
- Abstract
The genus Miroculis Edmunds, 1963 (Ephemeroptera: Leptophlebiidae) is represented by 23 species: two of them aredescribed based solely on nymphs, 10 based solely on male adults, and three based on nymphs and adults (Domínguez et al., 2006; Gama-Neto Hamada, 2013, 2014; Raimundi et al., 2017). Currently, the genus is represented by six species in Roraima State, Brazil, all are described as adults but only one of them has the nymphal stage described (Gama-Neto Hamada, 2013, 2014; Gama-Neto et al., 2018; Raimundi et al., 2017).
- Published
- 2018
- Full Text
- View/download PDF
24. CHL1 gene acts as a tumor suppressor in human neuroblastoma.
- Author
-
Ognibene M, Pagnan G, Marimpietri D, Cangelosi D, Cilli M, Benedetti MC, Boldrini R, Garaventa A, Frassoni F, Eva A, Varesio L, Pistoia V, and Pezzolo A
- Abstract
Neuroblastoma is an aggressive, relapse-prone childhood tumor of the sympathetic nervous system that accounts for 15% of pediatric cancer deaths. A distal portion of human chromosome 3p is often deleted in neuroblastoma, this region may contain one or more putative tumor suppressor genes. A 2.54 Mb region at 3p26.3 encompassing the smallest region of deletion pinpointed CHL1 gene, the locus for neuronal cell adhesion molecule close homolog of L1. We found that low CHL1 expression predicted poor outcome in neuroblastoma patients. Here we have used two inducible cell models to analyze the impact of CHL1 on neuroblastoma biology. Over-expression of CHL1 induced neurite-like outgrowth and markers of neuronal differentiation in neuroblastoma cells, halted tumor progression, inhibited anchorage-independent colony formation, and suppressed the growth of human tumor xenografts. Conversely, knock-down of CHL1 induced neurite retraction and activation of Rho GTPases, enhanced cell proliferation and migration, triggered colony formation and anchorage-independent growth, accelerated growth in orthotopic xenografts mouse model. Our findings demonstrate unambiguously that CHL1 acts as a regulator of proliferation and differentiation of neuroblastoma cells through inhibition of the MAPKs and Akt pathways. CHL1 is a novel candidate tumor suppressor in neuroblastoma, and its associated pathways may represent a promising target for future therapeutic interventions., Competing Interests: CONFLICTS OF INTEREST The authors declare no conflicts of interest.
- Published
- 2018
- Full Text
- View/download PDF
25. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency.
- Author
-
Callea F, Giovannoni I, Francalanci P, Boldrini R, Faa G, Medicina D, Nobili V, Desmet VJ, Ishak K, Seyama K, and Bellacchio E
- Subjects
- Animals, Calcium metabolism, Genotype, Humans, Liver metabolism, Liver pathology, Medical Records, Mutation genetics, Retrospective Studies, alpha 1-Antitrypsin genetics, alpha 1-Antitrypsin Deficiency genetics, Inclusion Bodies metabolism, alpha 1-Antitrypsin metabolism, alpha 1-Antitrypsin Deficiency metabolism
- Abstract
Background: Alpha-1-antitrypsin (AAT) deficiency (AATD) of Z, Mmalton, Siiyama type is associated with liver storage of the mutant proteins and liver disease. The Z variant can be diagnosed on isoelectric focusing (IEF) while Mmalton and Siiyama may be missed or misdiagnosed with this technique. Therefore, molecular analysis is mandatory for their characterization. In particular, that holds true for the Mmalton variant as on IEF profile it resembles the wild M2 subtype., Methods: This is a retrospective analysis involving review of medical records and of liver biopsy specimens from a series of Mmalton, Z and Siiyama Alpha-1-antitrypsin deficiency patients. The review has been implemented by additional histological stains, electron microscopic observations and 3-D modeling studies of the sites of the mutations., Results: Z, Mmalton and Siiyama liver specimen contained characteristic intrahepatocytic PAS-D globules. The globules differed in the three variants as only Mmalton cases showed dark basophilic precipitates within the AAT inclusions. The precipitates were visualized in haematoxylin-eosin (H.E.) stained preparations and corresponded to calcium precipitates as demonstrated by von Kossa staining. On immunohistochemistry, ZAAT inclusions were stained by polyclonal as well as monoclonal noncommercial anti-AAT antibody (AZT11), whilst Mmalton and Siiyama inclusion bodies remained negative with the monoclonal anti-Z antibody. 3-D protein analysis allowed to predict more severe misfolding of the Mmalton molecule as compared to Z and Siiyama that could trigger anomalous interaction with endoplasmic reticulum chaperon proteins, namely calcium binding proteins., Conclusions: Mmalton AAT inclusion bodies contain calcium precipitates inside them that allow the differential diagnosis with Siiyama and ZAAT inclusions in routine histological sections. The study has confirmed the specificity of the monoclonal AZT11 for the Z mutant. Thus, the combination of these two features is crucial for the distinction between the three variants and for predicting the genotype, whose confirmation would definitely require molecular analysis. Our study provides new data on the pathomorphogenesis of Mmalton inclusion bodies whose mineralization could play a central role in disease pathogenesis of Mmalton that is distinct from the Z and Siiyama variants. Calcium is known to be a major effector of cell death either via the increased intracellular concentration or the alteration of homeostasis.
- Published
- 2018
- Full Text
- View/download PDF
26. Congenital Rhabdomyosarcoma: a different clinical presentation in two cases.
- Author
-
Russo I, Di Paolo V, Gurnari C, Mastronuzzi A, Del Bufalo F, Di Paolo PL, Di Giannatale A, Boldrini R, and Milano GM
- Subjects
- Abdominal Neoplasms diagnostic imaging, Abdominal Neoplasms drug therapy, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Central Nervous System Neoplasms diagnostic imaging, Central Nervous System Neoplasms drug therapy, Central Nervous System Neoplasms secondary, Fatal Outcome, Female, Humans, Infant, Newborn, Male, Neoplasms, Multiple Primary diagnostic imaging, Neoplasms, Multiple Primary drug therapy, Rhabdomyosarcoma diagnostic imaging, Rhabdomyosarcoma drug therapy, Rhabdomyosarcoma secondary, Tomography, X-Ray Computed, Treatment Outcome, Abdominal Neoplasms congenital, Neoplasms, Multiple Primary congenital, Rhabdomyosarcoma congenital
- Abstract
Background: Rhabdomyosarcoma (RMS), one of the most common soft tissue sarcomas of childhood, is very rare in the neonatal period (0.4-2% of cases). In order to gain a deeper understanding of this disease at such age, patient and tumor features, as well as treatment modality and outcome need to be reported., Case Presentation: We describe two cases with congenital RMS treated at Bambino Gesù Children's Hospital between 2000 and 2016. They represent only 2.24% of all RMS patients diagnosed during that period in our Institution; this data is in agreement with the incidence reported in the literature. They reflect the two different clinical forms in which the disease may manifest itself. One patient, with the alveolar subtype (positive for specific PAX3-FOXO1 fusion transcript) and disseminated disease, had a fatal outcome with central nervous system (CNS) progression despite conventional and high dose chemotherapy. The other child, with the localized embryonal subtype, was treated successfully with conservative surgery and conventional chemotherapy, including prolonged maintenance therapy. He is disease free at 7 years of follow-up., Conclusions: RMS can also be diagnosed during the neonatal period. Given the young age, disease management is often challenging, and especially for the alveolar subtype, the outcome is dismal despite intensified multimodality therapy. In fact, it characteristically manifests with multiple subcutaneous nodules and progression most commonly occurs in the CNS (Rodriguez-Galindo et al., Cancer 92(6):1613-20, 2001). In this context, CNS prophylaxis could play a role in preventing leptomeningeal dissemination, and molecular studies can allow a deeper tumor characterization, treatment stratification and identification of new potential therapeutic targets.
- Published
- 2018
- Full Text
- View/download PDF
27. Reply: 22 Cases of Breast Implant-Associated ALCL: Awareness and Outcome Tracking from the Italian Ministry of Health.
- Author
-
Campanale A and Boldrini R
- Subjects
- Breast Neoplasms surgery, Humans, Italy, Lymphoma, Large-Cell, Anaplastic, Breast Implantation, Breast Implants
- Published
- 2018
- Full Text
- View/download PDF
28. Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome or Fowler syndrome: Report of a family and insight into the disease's mechanism.
- Author
-
Radio FC, Di Meglio L, Agolini E, Bellacchio E, Rinelli M, Toscano P, Boldrini R, Novelli A, Di Meglio A, and Dallapiccola B
- Subjects
- Alleles, Amino Acid Sequence genetics, Fetus pathology, Heme genetics, Heme metabolism, Humans, Hydranencephaly physiopathology, Hydrocephalus genetics, Membrane Transport Proteins physiology, Mutation, Receptors, Virus physiology, Vascular Diseases genetics, Hydranencephaly genetics, Membrane Transport Proteins genetics, Receptors, Virus genetics
- Abstract
Background: Fowler syndrome is a rare autosomal recessive disorder characterized by hydranencephaly-hydrocephaly and multiple pterygium due to fetal akinesia. To date, around 45 cases from 27 families have been reported, and the pathogenic bi-allelic mutations in FLVCR2 gene described in 15 families. The pathogenesis of this condition has not been fully elucidated so far., Methods: We report on an additional family with two affected fetuses carrying a novel homozygous mutation in FLVCR2 gene, and describe the impact of known mutants on the protein structural and functional impairment., Results: The present report confirms the genetic homogeneity of Fowler syndrome and describes a new FLVCR2 mutation affecting the protein function. The structural analysis of the present and previously published FLVCR2 mutations supports the hypothesis of a reduced heme import as the underlying disease's mechanism due to the stabilization of the occluded conformation or a protein misfolding., Conclusion: Our data suggest the hypothesis of heme deficiency as the major pathogenic mechanism of Fowler syndrome., (© 2018 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
29. Novel PNPLA1 mutations in two Italian siblings with autosomal recessive congenital ichthyosis.
- Author
-
Diociaiuti A, Pisaneschi E, Zambruno G, Angioni A, Novelli A, Boldrini R, and El Hachem M
- Subjects
- Child, Preschool, Female, Humans, Italy, Genes, Recessive, Ichthyosis, Lamellar genetics, Lipase genetics, Mutation, Missense, Siblings
- Published
- 2018
- Full Text
- View/download PDF
30. Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.
- Author
-
Di Paolo V, Russo I, Boldrini R, Ravà L, Pezzullo M, Benedetti MC, Galardi A, Colletti M, Rota R, Orlando D, Crocoli A, Peinado H, Milano GM, and Di Giannatale A
- Subjects
- Adolescent, Biomarkers, Tumor genetics, Child, Child, Preschool, Disease-Free Survival, Female, Gene Expression Regulation, Neoplastic, Humans, Infant, Infant, Newborn, Male, Neovascularization, Pathologic pathology, Platelet Endothelial Cell Adhesion Molecule-1 genetics, Rhabdomyosarcoma pathology, Vascular Endothelial Growth Factor A genetics, Endoglin genetics, Neovascularization, Pathologic genetics, Rhabdomyosarcoma genetics
- Abstract
Background: The Intratumoral Microvessel Density (IMVD) is commonly used to quantify tumoral vascularization and is usually assessed by pan-endothelial markers, such as CD31. Endoglin (CD105) is a protein predominantly expressed in proliferating endothelium and the IMVD determined by this marker measures specifically the neovascularization. In this study, we investigated the CD105 expression in pediatric rhabdomyosarcoma and assessed the neovascularization by using the angiogenic ratio IMVD-CD105 to IMVD-CD31., Methods: Paraffin-embedded archival tumor specimens were selected from 65 pediatric patients affected by rhabdomyosarcoma. The expression levels of CD105, CD31 and Vascular Endothelial Growth Factor (VEGF) were investigated in 30 cases (18 embryonal and 12 alveolar) available for this study. The IMVD-CD105 to IMVD-CD31 expression ratio was correlated with clinical and pathologic features of these patients., Results: We found a specific expression of endoglin (CD105) in endothelial cells of all the rhabdomyosarcoma specimens analyzed. We observed a significant positive correlation between the IMVD individually measured by CD105 and CD31. The CD105/CD31 expression ratio was significantly higher in patients with lower survival and embryonal histology. Indeed, patients with a CD105/CD31 expression ratio < 1.3 had a significantly increased OS (88%, 95%CI, 60%-97%) compared to patients with higher values (40%, 95%CI, 12%-67%). We did not find any statistical correlation among VEGF and EFS, OS and CD105/CD31 expression ratio., Conclusion: CD105 is expressed on endothelial cells of rhabdomyosarcoma and represent a useful tool to quantify neovascularization in this tumor. If confirmed by further studies, these results will indicate that CD105 is a potential target for combined therapies in rhabdomyosarcoma.
- Published
- 2018
- Full Text
- View/download PDF
31. 22 Cases of Breast Implant-Associated ALCL: Awareness and Outcome Tracking from the Italian Ministry of Health.
- Author
-
Campanale A, Boldrini R, and Marletta M
- Subjects
- Adult, Aged, Databases, Factual, Female, Follow-Up Studies, Humans, Incidence, Italy, Lymphoma, Large-Cell, Anaplastic diagnosis, Lymphoma, Large-Cell, Anaplastic epidemiology, Middle Aged, Retrospective Studies, Breast Implantation, Lymphoma, Large-Cell, Anaplastic etiology, Postoperative Complications diagnosis, Postoperative Complications epidemiology
- Abstract
Background: To date, 359 cases of anaplastic large cell lymphoma (ALCL) in women with breast implants (breast implant-associated ALCL [BIA-ALCL]) worldwide have been reported among more than 10 million patients who have received implants, but health care authorities suspect this is a possible underestimation, and the limited number of cases makes it difficult to clarify its cause. The General Directorate of Medical Devices and Pharmaceutical Services of the Italian Ministry of Health has examined and studied the Italian BIA-ALCL cases., Methods: An official document has been diffused to all medical associations, aiming at encouraging all physicians to notify each BIA-ALCL case. A retrospective study has been performed on the notified BIA-ALCL cases collected in the database named Dispovigilance., Results: Research on Dispovigilance returns a list of 22 BIA-ALCL cases. The mean patient age was 49.6 years (range, 30 to 71 years). The average time to the onset of the symptoms was 6.8 years (range, 1 to 22 years). The average time to diagnosis was 7.8 years (range, 4 to 22 years). The estimated incidence of the Italian BIA-ALCL cases related to 2015 is 2.8 per 100,000 patients., Conclusions: The pathogenesis of BIA-ALCL remains unknown. The establishment of a national breast implant registry is needed to better understand some aspects of this disease. Future genetic studies on the population affected could clarify why only some patients with implants develop this disease.
- Published
- 2018
- Full Text
- View/download PDF
32. Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage.
- Author
-
Callea F, Giovannoni I, Sari S, Guldal E, Dalgic B, Akyol G, Sogo T, Al-Hussaini A, Maggiore G, Bartuli A, Boldrini R, Francalanci P, and Bellacchio E
- Subjects
- Afibrinogenemia blood, Afibrinogenemia pathology, Apolipoprotein B-100 blood, Child, Preschool, Endoplasmic Reticulum genetics, Endoplasmic Reticulum metabolism, Female, Fibrinogen chemistry, Fibrinogen metabolism, Hepatocytes chemistry, Hepatocytes metabolism, Hepatocytes pathology, Humans, Hypolipoproteinemias metabolism, Hypolipoproteinemias pathology, Liver metabolism, Liver pathology, Liver Diseases genetics, Liver Diseases pathology, Male, Middle Aged, Mutation, Protein Conformation, Structure-Activity Relationship, Afibrinogenemia genetics, Apolipoprotein B-100 genetics, Fibrinogen genetics, Hypolipoproteinemias genetics, Liver Diseases blood
- Abstract
p.R375W (Fibrinogen Aguadilla) is one out of seven identified mutations (Brescia, Aguadilla, Angers, Al du Pont, Pisa, Beograd, and Ankara) causing hepatic storage of the mutant fibrinogen γ. The Aguadilla mutation has been reported in children from the Caribbean, Europe, Japan, Saudi Arabia, Turkey, and China. All reported children presented with a variable degree of histologically proven chronic liver disease and low plasma fibrinogen levels. In addition, one Japanese and one Turkish child had concomitant hypo-APOB-lipoproteinemia of unknown origin. We report here on an additional child from Turkey with hypofibrinogenemia due to the Aguadilla mutation, massive hepatic storage of the mutant protein, and severe hypo-APOB-lipoproteinemia. The liver biopsy of the patient was studied by light microscopy, electron microscopy (EM), and immunohistochemistry. The investigation included the DNA sequencing of the three fibrinogen and APOB-lipoprotein regulatory genes and the analysis of the encoded protein structures. Six additional Fibrinogen Storage Disease (FSD) patients with either the Aguadilla, Ankara, or Brescia mutations were investigated with the same methodology. A molecular analysis revealed the fibrinogen gamma p.R375W mutation (Aguadilla) but no changes in the APOB and MTTP genes. APOB and MTTP genes showed no abnormalities in the other study cases. Light microscopy and EM studies of liver tissue samples from the child led to the demonstration of the simultaneous accumulation of both fibrinogen and APOB in the same inclusions. Interestingly enough, APOB-containing lipid droplets were entrapped within the fibrinogen inclusions in the hepatocytic Endoplasmic Reticulum (ER). Similar histological, immunohistochemical, EM, and molecular genetics findings were found in the other six FSD cases associated with the Aguadilla, as well as with the Ankara and Brescia mutations. The simultaneous retention of fibrinogen and APOB-lipoproteins in FSD can be detected in routinely stained histological sections. The analysis of protein structures unraveled the pathomorphogenesis of this unexpected phenomenon. Fibrinogen gamma chain mutations provoke conformational changes in the region of the globular domain involved in the "end-to-end" interaction, thus impairing the D-dimer formation. Each monomeric fibrinogen gamma chain is left with an abnormal exposure of hydrophobic patches that become available for interactions with APOB and lipids, causing their intracellular retention and impairment of export as a secondary unavoidable phenomenon., Competing Interests: All authors indicated they have no potential conflicts of interest to disclose.
- Published
- 2017
- Full Text
- View/download PDF
33. Lipoid Proteinosis: A Previously Unrecognized Mutation and Therapeutic Response to Acitretin.
- Author
-
Carnevale C, Castiglia D, Diociaiuti A, Proto V, Giancristoforo S, Boldrini R, Zambruno G, and El Hachem M
- Subjects
- Acitretin adverse effects, Administration, Oral, Adolescent, DNA Mutational Analysis, Genetic Predisposition to Disease, Humans, Keratolytic Agents adverse effects, Lipoid Proteinosis of Urbach and Wiethe diagnosis, Male, Phenotype, Tomography, X-Ray Computed, Treatment Outcome, Acitretin administration & dosage, Extracellular Matrix Proteins genetics, Keratolytic Agents administration & dosage, Lipoid Proteinosis of Urbach and Wiethe drug therapy, Lipoid Proteinosis of Urbach and Wiethe genetics, Mutation
- Published
- 2017
- Full Text
- View/download PDF
34. Pediatric Chronic Intestinal Failure in Italy: Report from the 2016 Survey on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP).
- Author
-
Diamanti A, Capriati T, Gandullia P, Di Leo G, Lezo A, Lacitignola L, Spagnuolo MI, Gatti S, D'Antiga L, Verlato G, Roggero P, Amarri S, Baldassarre ME, Cirillo F, Elia D, Boldrini R, Campanozzi A, Catassi C, Aloi M, Romano C, Candusso M, Cecchi N, Bellini T, Tyndall E, Fusaro F, Caldaro T, Alberti D, Gamba P, Lima M, Bagolan P, De Ville de Goyet J, Dall'Oglio L, Spada M, and Grandi F
- Subjects
- Adolescent, Child, Child, Preschool, Chronic Disease, Data Collection, Female, Humans, Incidence, Infant, Intestinal Diseases therapy, Italy epidemiology, Male, Nutritional Status, Parenteral Nutrition, Home, Prevalence, Intestinal Diseases epidemiology, Intestinal Diseases etiology
- Abstract
Background: Intestinal failure (IF) is the reduction in functioning gut mass below the minimal level necessary for adequate digestion and absorption of nutrients and fluids for weight maintenance in adults or for growth in children. There is a paucity of epidemiologic data on pediatric IF. The purpose of this study was to determine the prevalence, incidence, regional distribution and underlying diagnosis of pediatric chronic IF (CIF) requiring home parenteral nutrition (HPN) in Italy., Methods: Local investigators were selected in 19 Italian centers either of reference for pediatric HPN or having pediatric gastroenterologists or surgeons on staff and already collaborating with the Italian Society for Pediatric Gastroenterology, Hepatology and Nutrition with regard to IF. Data requested in this survey for children at home on Parenteral Nutrition (PN) on 1 December 2016 included patient initials, year of birth, gender, family's place of residence and underlying diagnosis determining IF., Results: We recorded 145 CIF patients on HPN aged ≤19 years. The overall prevalence was 14.12/million inhabitants (95% CI: 9.20-18.93); the overall incidence was 1.41/million inhabitant years (95% CI: 0.53-2.20)., Conclusion: Our survey provides new epidemiological data on pediatric CIF in Italy; these data may be quantitatively useful in developing IF care strategy plans in all developed countries., Competing Interests: The authors declare no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF
35. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
- Author
-
Terenziani M, Bisogno G, Boldrini R, Cecchetto G, Conte M, Boschetti L, De Pasquale MD, Biasoni D, Inserra A, Siracusa F, Basso ME, De Leonardis F, Di Pinto D, Barretta F, Spreafico F, and D'Angelo P
- Subjects
- Adolescent, Bleomycin administration & dosage, Child, Child, Preschool, Cisplatin administration & dosage, Combined Modality Therapy, Etoposide administration & dosage, Female, Follow-Up Studies, Humans, Infant, Male, Neoplasm Staging, Neoplasms, Germ Cell and Embryonal pathology, Ovarian Neoplasms pathology, Ovariectomy, Prognosis, Prospective Studies, Survival Rate, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Neoplasms, Germ Cell and Embryonal therapy, Ovarian Neoplasms therapy
- Abstract
Objective: Malignant ovarian germ cell tumors (MOGCT) carry an excellent prognosis, and the treatment aims to achieve results with the least possible treatment-related morbidity. The aim of this study was to assess the outcomes of pediatric patients with MOGCT., Methods: Patients were treated according to their stage: surgery and surveillance for stage I; a modified bleomycin-etoposide-cisplatin (BEP) regimen for stages II (three cycles), III, and IV (three cycles) with surgery on residual disease., Results: Seventy-seven patients were enrolled (median age 11.8 years), 26 with dysgerminoma (Dysg), 13 with immature teratoma and elevated serum alpha-fetoprotein levels (IT + AFP), and 38 with nondysgeminoma (Non-Dysg) staged as follows: 27 stage I, 13 stage II, 32 stage III, 5 stage IV. Among evaluable patients in stage I (5-year event-free survival [EFS] 72.1% [95% CI: 56.4-92.1%]; 5-year overall survival [OS] 100%), seven relapsed (three patients with Dysg and four patients with Non-Dysg) and were rescued with chemotherapy (plus surgery in three patients). Among the evaluable patients with stages II-IV, 48 (98%) achieved complete remission after chemotherapy ± surgery, one (IT + AFP, stage IV) had progressive disease. In the whole series (median follow-up 80 months), the 5-year OS and EFS were 98.5% (95% CI: 95.6-100%) and 84.5% (95% CI: 76.5-93.5%)., Conclusions: We confirm the excellent outcome for MOGCT. Robust data are lacking on surgical staging, surveillance for Non-Dysg with stage I, the management of IT + AFP, and the most appropriate BEP regimen. As pediatric oncologists, we support the role of surveillance after proper surgical staging providing cases are managed by experts at specialized pediatric centers., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
36. Corinnella lourii , a rare new species of Baetidae (Ephemeroptera) from central Brazil.
- Author
-
Salles FF, Victoriano AS, Boldrini R, and Cabette HRS
- Subjects
- Animals, Brazil, Nymph, Rivers, Ephemeroptera
- Abstract
A new species of the rare genus Corinnella is described based on nymphs from the Rio Pindaíba, a river located close to the Cerrado - Amazonian border. The new species is more related to C. eximia than to C. thomasi, but can be distinguished from them by the following combination of characters: 1) distomedial emargination of labrum broad and with very small process; 2) maxillary palp 2.0× length of galea-lacinia; 3) posterior margin of terga I-IX with pointed spaced spines; 4) claws with four denticles.
- Published
- 2017
- Full Text
- View/download PDF
37. A novel fibrinogen gamma chain mutation (c.1096C>G; p.His340Asp), fibrinogen Ankara, causing hypofibrinogenaemia and hepatic storage.
- Author
-
Callea F, Giovannoni I, Sari S, Aksu AU, Esendagly G, Dalgic B, Boldrini R, Akyol G, Francalanci P, and Bellacchio E
- Subjects
- Adult, Child, Female, Humans, Infant, Male, Afibrinogenemia genetics, Fibrinogen genetics, Liver pathology, Mutation genetics
- Published
- 2017
- Full Text
- View/download PDF
38. PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.
- Author
-
Melaiu O, Mina M, Chierici M, Boldrini R, Jurman G, Romania P, D'Alicandro V, Benedetti MC, Castellano A, Liu T, Furlanello C, Locatelli F, and Fruci D
- Subjects
- Adolescent, Adult, Antigens, CD genetics, Antigens, CD immunology, Azepines administration & dosage, B7-H1 Antigen immunology, Biomarkers, Tumor genetics, Cell Line, Tumor, Child, Child, Preschool, Female, Gene Expression Regulation, Neoplastic drug effects, Genes, MHC Class I immunology, Humans, Infant, Lymphocytes, Tumor-Infiltrating drug effects, Lymphocytes, Tumor-Infiltrating pathology, Male, Middle Aged, Molecular Targeted Therapy, N-Myc Proto-Oncogene Protein immunology, Neuroblastoma drug therapy, Neuroblastoma immunology, Neuroblastoma pathology, Prognosis, Programmed Cell Death 1 Receptor genetics, Proto-Oncogene Proteins c-myc immunology, Triazoles administration & dosage, Lymphocyte Activation Gene 3 Protein, B7-H1 Antigen genetics, Genes, MHC Class I genetics, N-Myc Proto-Oncogene Protein genetics, Neuroblastoma genetics, Proto-Oncogene Proteins c-myc genetics
- Abstract
Purpose: This study sought to evaluate the expression of programmed cell death-ligand-1 (PD-L1) and HLA class I on neuroblastoma cells and programmed cell death-1 (PD-1) and lymphocyte activation gene 3 (LAG3) on tumor-infiltrating lymphocytes to better define patient risk stratification and understand whether this tumor may benefit from therapies targeting immune checkpoint molecules. Experimental Design: In situ IHC staining for PD-L1, HLA class I, PD-1, and LAG3 was assessed in 77 neuroblastoma specimens, previously characterized for tumor-infiltrating T-cell density and correlated with clinical outcome. Surface expression of PD-L1 was evaluated by flow cytometry and IHC in neuroblastoma cell lines and tumors genetically and/or pharmacologically inhibited for MYC and MYCN. A dataset of 477 human primary neuroblastomas from GEO and ArrayExpress databases was explored for PD-L1, MYC, and MYCN correlation. Results: Multivariate Cox regression analysis demonstrated that the combination of PD-L1 and HLA class I tumor cell density is a prognostic biomarker for predicting overall survival in neuroblastoma patients ( P = 0.0448). MYC and MYCN control the expression of PD-L1 in neuroblastoma cells both in vitro and in vivo Consistently, abundance of PD-L1 transcript correlates with MYC expression in primary neuroblastoma. Conclusions: The combination of PD-L1 and HLA class I represents a novel prognostic biomarker for neuroblastoma. Pharmacologic inhibition of MYCN and MYC may be exploited to target PD-L1 and restore an efficient antitumor immunity in high-risk neuroblastoma. Clin Cancer Res; 23(15); 4462-72. ©2017 AACR ., (©2017 American Association for Cancer Research.)
- Published
- 2017
- Full Text
- View/download PDF
39. New distributional records and life stage description of Caenis species (Ephemeroptera: Caenidae) from Brazil.
- Author
-
Lima LRC and Boldrini R
- Subjects
- Animal Structures, Animals, Body Size, Brazil, Organ Size, Ephemeroptera
- Abstract
The genus Caenis Stephens, 1835 is well represented in South America with 24 recorded species (14 in Brazil). Based on additional material from Brazil, we describe for the first time the nymphal and egg stages of C. reissi, and re-describe the eggs of C. cuniana. New distributional records for these species and Caenis elidioi are given, and C. teipunensis (previously described from Venezuela) is reported for the first time from Brazil.
- Published
- 2017
- Full Text
- View/download PDF
40. Global Adverse Event Reports of Breast Implant-Associated ALCL: An International Review of 40 Government Authority Databases.
- Author
-
Srinivasa DR, Miranda RN, Kaura A, Francis AM, Campanale A, Boldrini R, Alexander J, Deva AK, Gravina PR, Medeiros LJ, Nast K, Butler CE, and Clemens MW
- Subjects
- Adult, Aged, Aged, 80 and over, Algorithms, Female, Global Health, Humans, International Cooperation, Lymphoma, Large-Cell, Anaplastic epidemiology, Middle Aged, Postoperative Complications epidemiology, Breast Implants adverse effects, Databases, Factual, Lymphoma, Large-Cell, Anaplastic etiology, Postoperative Complications etiology, Product Surveillance, Postmarketing
- Abstract
Background: Tracking world cases of breast implant-associated anaplastic large cell lymphoma (ALCL) is currently limited to patient registries at a few academic centers, dependent upon patient referral and case reports in the literature. The purpose of this study was to review and compare federal database adverse event reports of breast implant-associated ALCL encompassing the major breast implant markets worldwide., Methods: Federal implantable device regulatory bodies were contacted and database queries were performed for 40 countries. Demographics, device characteristics, pathology, treatment modalities, and outcomes were assessed when available., Results: For the countries queried, 363 unique cases were reported for breast implant-associated ALCL. Search terms "anaplastic" and "ALCL" were queried of the U.S. Manufacturer and User Facility Device Experience (MAUDE) database and yielded 258 unique cases as of September 2015, of which only 130 had pathologic markers performed. Implant surface was textured significantly more than smooth (50 percent versus 4.2 percent; p = 0.0001). Treatment, when reported (n = 136), included explantation [n = 125 (91.9 percent)], chemotherapy [n = 42 (30.8 percent)], radiation therapy [n = 25 (18.4 percent)], and/or stem cell transplant [n = 9 (6.6 percent)], and five deaths were reported., Conclusions: Federal reporting of breast implant-associated ALCL has limitations in providing clinical history, treatment, and oncologic follow-up. Worldwide and country-specific total and textured implant sales data are needed to determine critical incidence and prevalence analysis. International multi-institutional collaborations and centralized tissue consortiums working in concert with federal authorities are necessary to acquire accurate complete data on breast implant-associated ALCL.
- Published
- 2017
- Full Text
- View/download PDF
41. MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma.
- Author
-
Brandetti E, Veneziani I, Melaiu O, Pezzolo A, Castellano A, Boldrini R, Ferretti E, Fruci D, Moretta L, Pistoia V, Locatelli F, and Cifaldi L
- Abstract
Neuroblastoma (NB) is the most common extracranial solid tumor occurring in childhood. Amplification of the MYCN oncogene is associated with poor prognosis. Downregulation on NB cells of ligands recognized by Natural Killer (NK) cell-activating receptors, involved in tumor cell recognition and lysis, may contribute to tumor progression and relapse. Here, we demonstrate that in human NB cell lines MYCN expression inversely correlates with that of ligands recognized by NKG2D and DNAM1 activating receptors in human NB cell lines. In the MYCN-inducible Tet-21/N cell line, downregulation of MYCN resulted in enhanced expression of the activating ligands MICA, ULBPs and PVR, which rendered tumor cells more susceptible to recognition and lysis mediated by NK cells. Conversely, a MYCN non-amplified NB cell line transfected with MYCN showed an opposite behavior compared with control cells. Consistent with these findings, an inverse correlation was detected between the expression of MYCN and that of ligands for NK-cell-activating receptors in 12 NB patient specimens both at mRNA and protein levels. Taken together, these results provide the first demonstration that MYCN acts as an immunosuppressive oncogene in NB cells that negatively regulates the expression of ligands for NKG2D and DNAM-1 NK-cell-activating receptors. Our study provides a clue to exploit MYCN expression levels as a biomarker to predict the efficacy of NK-cell-based immunotherapy in NB patients.
- Published
- 2017
- Full Text
- View/download PDF
42. Pediatric adrenocortical neoplasms: immunohistochemical expression of p57 identifies loss of heterozygosity and abnormal imprinting of the 11p15.5.
- Author
-
Giovannoni I, Boldrini R, Benedetti MC, Inserra A, De Pasquale MD, and Francalanci P
- Subjects
- Cell Proliferation, Child, Preschool, Chromosomes, Human, Pair 11, Diagnosis, Differential, Female, Gene Expression Regulation, Humans, Immunohistochemistry, Infant, Infant, Newborn, Male, Microsatellite Repeats, Adrenal Cortex Neoplasms diagnosis, Adrenal Cortex Neoplasms genetics, Genomic Imprinting, Kidney Neoplasms diagnosis, Kidney Neoplasms genetics, Loss of Heterozygosity
- Abstract
Background: Diagnosis of adrenocortical neoplasms (ACN), in pediatric age, is based on Wieneke criteria. The p57, a cyclin-dependent kinase inhibitor, acts to negatively regulate cell proliferation and is frequently found dysregulated in cancer. The identification of loss of heterozygosity (LOH) of 11p15, containing the p57 gene, could be a tool for differential diagnosis of benign and malignant ACN., Methods: Immunohistochemistry with anti-p57 and microsatellite markers analysis of 11p15 region to value LOH were made in both ACN and surrounded normal adrenal cortex., Results: Nine ACN, two clinically benign, two uncertain, and five malignant, were diagnosed. Positive p57 cells were evident in normal adrenal cortex and in one histologically benign ACN. A low/absent expression of p57 was documented in eight ACN independently from the classification on the basis of pathological and clinical criteria. Microsatellite marker analysis confirmed the LOH of 11p15 region in the same ACN., Conclusion: LOH of 11p15 has a high prognostic value suggesting the p57 gene is important in ACN pathogenesis. Immunohistochemistry for p57 is a simple and cheap tool that can be used to quickly identify LOH of 11p15 in ACN.
- Published
- 2017
- Full Text
- View/download PDF
43. Structural Defects of Laminin β3 N-terminus Underlie Junctional Epidermolysis Bullosa with Altered Granulation Tissue Response.
- Author
-
El Hachem M, Fortugno P, Palmeri A, Helmer-Citterich M, Diociaiuti A, Proto V, Boldrini R, Zambruno G, and Castiglia D
- Subjects
- Child, Granulation Tissue, Humans, Male, Kalinin, Cell Adhesion Molecules genetics, Epidermolysis Bullosa, Junctional genetics
- Abstract
Mutations in the laminin-332 (α3Aβ3γ2) genes cause junctional epidermolysis bullosa (JEB), a recessively inherited disease characterized by blistering and altered wound repair. In addition, specific mutations that affect the N-terminus of the α3A chain cause a JEB-related non-blistering condition characterized by chronic production of granulation tissue, suggesting a critical role of this region in epithelial-mesenchymal communication. We report here a 9-year-old patient with JEB with a few long-standing skin ulcers with prominent granulation tissue in the absence of active blistering. He bears a homozygous missense mutation, p.Gly254Asp, within the first laminin epidermal growth factor-like (LE) repeat of the β3 short arm. We show that p.Gly254Asp causes mis-folding of the LE motif, leading to reduced secretion of laminin-332 and structural alterations of the cutaneous basement membrane zone. These findings demonstrate, in a patient in vivo, that the β3 short arm is also involved in the outcome of the granulation tissue response.
- Published
- 2016
- Full Text
- View/download PDF
44. Start codon mutation of GYG1 causing late-onset polyglucosan body myopathy with nemaline rods.
- Author
-
Tasca G, Fattori F, Monforte M, Hedberg-Oldfors C, Sabatelli M, Udd B, Boldrini R, Bertini E, Ricci E, and Oldfors A
- Subjects
- Aged, 80 and over, DNA Mutational Analysis, Glycogen Storage Disease complications, Glycogen Storage Disease diagnostic imaging, Humans, Male, Myopathies, Nemaline diagnostic imaging, Nervous System Diseases complications, Nervous System Diseases diagnostic imaging, Codon, Initiator genetics, Glucosyltransferases genetics, Glycogen Storage Disease genetics, Glycoproteins genetics, Mutation genetics, Myopathies, Nemaline complications, Myopathies, Nemaline genetics, Nervous System Diseases genetics
- Published
- 2016
- Full Text
- View/download PDF
45. Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.
- Author
-
Gasparini P, Casanova M, Villa R, Collini P, Alaggio R, Zin A, Bonvini P, Antonescu CR, Boldrini R, Caserini R, Moro M, Centonze G, Meazza C, Massimino M, Bergamaschi L, Luksch R, Chiaravalli S, Bisogno G, Zaffaroni N, Daidone MG, Sozzi G, and Ferrari A
- Subjects
- Adolescent, Adult, Anaplastic Lymphoma Kinase, Cell Differentiation, Cell Line, Tumor, Child, Child, Preschool, Cohort Studies, Female, Gene Rearrangement, Humans, Infant, Infant, Newborn, Male, Neoplasm Metastasis, RNA, Small Interfering genetics, Receptor Protein-Tyrosine Kinases metabolism, Treatment Outcome, Young Adult, Mesenchymal Stem Cells physiology, Muscle, Skeletal pathology, Receptor Protein-Tyrosine Kinases genetics, Rhabdomyosarcoma diagnosis, Rhabdomyosarcoma genetics
- Abstract
Rhabdomyosarcoma (RMS) is the most frequent soft tissue tumor in childhood and arises from immature mesenchymal cells committed to skeletal muscle differentiation. Anaplastic Lymphoma Kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in several cancers. Moreover, ALK full-length receptor protein has been observed in RMS, although its clinical and functional significance is yet controversial. The role of ALK and its clinical relevance were investigated in a selected cohort of 74 FFPE pediatric RMS and a panel of RMS cell lines, evaluating its gene and protein status, utilizing Fluorescent In Situ Hybridization (FISH), immunohistochemistry (IHC) and Western blot approaches. Moreover, to get insight into its possible therapeutic relevance, effects of ALK silencing on cell proliferation, invasion and apoptosis were studied in RMS cells. ALK IHC positivity was significantly correlated with gene copy number gain, the alveolar subtype, PAX3/7-FOXO1 rearrangements, the presence of metastasis at diagnosis and a worse overall outcome. Furthermore, EML4-ALK fusion gene associated with higher protein expression was identified in an embryonal RMS. ALK silencing in RH30 ALK positive cells strongly inhibited invasion capability. Overall, our data suggest a potential role of ALK in pediatric RMS.
- Published
- 2016
- Full Text
- View/download PDF
46. Frequent Occurrence of Aplasia Cutis Congenita in Bullous Dermolysis of the Newborn.
- Author
-
Diociaiuti A, Castiglia D, Giancristoforo S, Guerra L, Proto V, Dotta A, Boldrini R, Zambruno G, and El Hachem M
- Subjects
- Biopsy, Ectodermal Dysplasia pathology, Epidermolysis Bullosa Dystrophica pathology, Female, Humans, Infant, Newborn, Male, Microscopy, Electron, Ectodermal Dysplasia diagnosis, Epidermolysis Bullosa Dystrophica diagnosis
- Abstract
Bullous dermolysis of the newborn (BDN) is a subtype of dystrophic epidermolysis bullosa characterized by rapid improvement in skin fragility within the first months of life, associated with typical immunofluorescence and ultrastructural features. Inheritance can be autosomal dominant or recessive. We report here 4 cases of BDN, 2 of which presented with aplasia cutis congenita of the lower extremities. All patients improved rapidly and blister formation ceased by the third month of life in 3 cases. In these patients only residual milia, nail dystrophies and atrophic scarring at sites of aplasia cutis were visible by one year. Family history indicated dominant inheritance in 2 cases, confirmed by identification of COL7A1 mutation. Molecular analysis also revealed recessive inheritance in the 2 sporadic cases. A literature search identified several patients with BDN born with skin defects localized to the lower extremities. In conclusion, these findings indicate that aplasia cutis congenita is not an infrequent manifestation of BDN.
- Published
- 2016
- Full Text
- View/download PDF
47. Acral skin atrophy in an infant: an early clue to Kindler syndrome diagnosis.
- Author
-
Diociaiuti A, Zambruno G, Giancristoforo S, Proto V, Boldrini R, Castiglia D, and El Hachem M
- Subjects
- Humans, Infant, Male, Blister diagnosis, Epidermolysis Bullosa diagnosis, Periodontal Diseases diagnosis, Photosensitivity Disorders diagnosis, Skin pathology
- Published
- 2016
- Full Text
- View/download PDF
48. Mediastinal Germ Cell Tumors in Pediatric Patients: A Report From the Italian Association of Pediatric Hematology and Oncology.
- Author
-
De Pasquale MD, Crocoli A, Conte M, Indolfi P, D'Angelo P, Boldrini R, Terenziani M, and Inserra A
- Subjects
- Adolescent, Child, Preschool, Disease-Free Survival, Female, Follow-Up Studies, Humans, Infant, Italy epidemiology, Male, Prospective Studies, Survival Rate, Mediastinal Neoplasms mortality, Mediastinal Neoplasms therapy, Teratoma mortality, Teratoma therapy
- Abstract
Background: Primary mediastinal germ cell tumors (GCTs) are rare in children and still represent a challenge for both adult and pediatric oncologists because of their worse outcome compared to their gonadal counterpart., Procedure: Prospectively collected data concerning patients enrolled in the Italian Association of Pediatric Haematology and Oncology study on malignant GCTs (AIEOP TCGM 2004) protocol for the treatment of GCTs were analyzed. Patients with malignant mediastinal primary GCTs were included in this study. Data regarding patients with newly diagnosed mediastinal teratoma were also collected., Results: From 2005 to 2013, 20 children diagnosed with mediastinal GCTs were registered in AIEOP TCGM 2004 protocol. With a median follow-up of 89 months (range 35-123), the overall survival (OS) and event free survival (EFS) rates were 100% for teratoma and 90% for malignant GCTs., Conclusions: We confirm the favorable outcome of children affected by mediastinal teratoma and malignant GCTs. For malignant tumors, further studies on the clinical characteristics and genetic signatures on tumor samples might be necessary to better understand differences observed in high-risk patients and to assist the development of more effective treatment for this subgroup., (© 2016 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
49. Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.
- Author
-
Peca D, Boldrini R, Johannson J, Shieh JT, Citti A, Petrini S, Salerno T, Cazzato S, Testa R, Messina F, Onofri A, Cenacchi G, Westermark P, Ullmann N, Cogo P, Cutrera R, and Danhaive O
- Published
- 2016
- Full Text
- View/download PDF
50. Surfactant Protein C-associated interstitial lung disease; three different phenotypes of the same SFTPC mutation.
- Author
-
Salerno T, Peca D, Menchini L, Schiavino A, Boldrini R, Esposito F, Danhaive O, and Cutrera R
- Subjects
- Child, Preschool, Diagnosis, Differential, Diagnostic Imaging, Female, Humans, Infant, Lung Diseases, Interstitial drug therapy, Male, Phenotype, Lung Diseases, Interstitial diagnosis, Lung Diseases, Interstitial genetics, Mutation, Pulmonary Surfactant-Associated Protein C genetics
- Abstract
Background: Monoallelic mutations of the Surfactant Protein C gene (SFTPC) are associated with Interstitial Lung Disease in children. I73T is the most common mutation, accounting for 30 % of all cases reported., Case Presentation: We describe three patients carrying the same I73T SPC mutation with very different phenotypes, clinical course (ranging from mild respiratory symptoms to death for respiratory failure) and outcome., Conclusions: The disease mechanisms associated with SP-C mutations suggest that the combination of individual genetic background and environmental factors contribute largely to the wide variability of clinical expression. Infants, children and adults with ILD of unknown etiology should be investigated for SP-C genetic abnormalities.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.